cytochrome P450 family 2 subfamily D member 6
E1583714
UNEXPLORED
Cytochrome P450 family 2 subfamily D member 6 (CYP2D6) is a highly polymorphic liver enzyme that metabolizes a wide range of clinically important drugs, significantly influencing individual responses to medications.
All labels observed (1)
| Label | Occurrences |
|---|---|
| cytochrome P450 family 2 subfamily D member 6 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T23399830 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: cytochrome P450 family 2 subfamily D member 6 Context triple: [CYP2D6, fullName, cytochrome P450 family 2 subfamily D member 6]
-
A.
cytochrome P450 family 2 subfamily C member 19
Cytochrome P450 family 2 subfamily C member 19 (CYP2C19) is a liver enzyme that metabolizes various clinically important drugs, including proton pump inhibitors, antidepressants, and the antiplatelet agent clopidogrel, with genetic variants significantly affecting individual drug response.
-
B.
CYP2J2
CYP2J2 is a human cytochrome P450 enzyme primarily expressed in the heart and other tissues, involved in the metabolism of various drugs and endogenous fatty acids.
-
C.
CYP2B6
CYP2B6 is a human liver cytochrome P450 enzyme that plays a key role in the metabolism of various drugs and xenobiotics.
-
D.
CYP3A4
CYP3A4 is a major human liver and intestinal enzyme of the cytochrome P450 family responsible for metabolizing a wide range of drugs and xenobiotics.
-
E.
cytochrome P450 superfamily
The cytochrome P450 superfamily is a large and diverse group of heme-containing enzymes that catalyze the oxidation of a wide variety of endogenous compounds and xenobiotics, playing key roles in drug metabolism and biosynthesis of hormones and lipids.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: cytochrome P450 family 2 subfamily D member 6 Target entity description: Cytochrome P450 family 2 subfamily D member 6 (CYP2D6) is a highly polymorphic liver enzyme that metabolizes a wide range of clinically important drugs, significantly influencing individual responses to medications.
-
A.
cytochrome P450 family 2 subfamily C member 19
Cytochrome P450 family 2 subfamily C member 19 (CYP2C19) is a liver enzyme that metabolizes various clinically important drugs, including proton pump inhibitors, antidepressants, and the antiplatelet agent clopidogrel, with genetic variants significantly affecting individual drug response.
-
B.
CYP2J2
CYP2J2 is a human cytochrome P450 enzyme primarily expressed in the heart and other tissues, involved in the metabolism of various drugs and endogenous fatty acids.
-
C.
CYP2B6
CYP2B6 is a human liver cytochrome P450 enzyme that plays a key role in the metabolism of various drugs and xenobiotics.
-
D.
CYP3A4
CYP3A4 is a major human liver and intestinal enzyme of the cytochrome P450 family responsible for metabolizing a wide range of drugs and xenobiotics.
-
E.
cytochrome P450 superfamily
The cytochrome P450 superfamily is a large and diverse group of heme-containing enzymes that catalyze the oxidation of a wide variety of endogenous compounds and xenobiotics, playing key roles in drug metabolism and biosynthesis of hormones and lipids.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.